'Keep on keeping on': persistence with lipid-lowering treatment in familial hypercholesterolaemia

被引:0
|
作者
Hegele, Robert A. [1 ,2 ]
机构
[1] Western Univ, Robarts Res Inst, 4288A-1151 Richmond St North, London, ON N6A 5B7, Canada
[2] Western Univ, Dept Med, 4288A-1151 Richmond St North, London, ON N6A 5B7, Canada
基金
加拿大健康研究院;
关键词
CARDIOVASCULAR-DISEASE; ADHERENCE;
D O I
10.1093/eurjpc/zwac297
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:318 / 319
页数:2
相关论文
共 50 条
  • [21] Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry
    D'Erasmo, Laura
    Bini, Simone
    Casula, Manuela
    Gazzotti, Marta
    Bertolini, Stefano
    Calandra, Sebastiano
    Tarugi, Patrizia
    Averna, Maurizio
    Iannuzzo, Gabriella
    Fortunato, Giuliana
    Catapano, Alberico L.
    Arca, Marcello
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (08) : 1038 - 1047
  • [22] Determinants of lipid-lowering medication prescribing in a multi-ethnic adult population diagnosed with familial hypercholesterolaemia in South London
    Ayoub, Aya
    Akyea, Ralph
    L'Esperance, Veline
    Ayis, Salma
    Parmar, Divya
    Durbaba, Stevo
    Fisher, Mark
    Patel, Riyaz
    Harding, Seeromanie
    Wierzbicki, Anthony S.
    Qureshi, Nadeem
    Molokhia, Mariam
    BRITISH JOURNAL OF GENERAL PRACTICE, 2023, 73
  • [23] Combined antihypertensive and lipid-lowering treatment
    Cesari, M
    Pessina, AC
    CURRENT HYPERTENSION REPORTS, 2004, 6 (04) : 300 - 306
  • [24] Lipid-lowering treatment and coronary atherosclerosis
    Goudev, A
    Jorgova, J
    Georgiev, D
    LANCET, 2001, 358 (9282): : 667 - 667
  • [25] Combined antihypertensive and lipid-lowering treatment
    Maurizio Cesari
    Achille C. Pessina
    Current Hypertension Reports, 2004, 6 : 300 - 306
  • [26] Unresolved issues in lipid-lowering treatment
    Tziomalos, Konstantinos
    PANMINERVA MEDICA, 2016, 58 (02) : 191 - 195
  • [27] EFFECT OF LIPID-LOWERING TREATMENT IN COMPOSITION AND FUNCTIONALITY OF LIPOPROTEINS IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA
    Puig, N.
    Benitez, S.
    Minambres, I.
    Rivas, A.
    Grau, M.
    Sanchez, J. L.
    Perez, A.
    ATHEROSCLEROSIS, 2019, 287 : E201 - E201
  • [28] ADHERENCE, COMPLIANCE, AND PERSISTENCE WITH LIPID-LOWERING THERAPIES: A SYSTEMATIC REVIEW
    Xu, Y.
    Worden, C.
    VALUE IN HEALTH, 2016, 19 (03) : A50 - A50
  • [29] Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes
    Thompson, Gilbert R.
    Seed, Mary
    Naoumova, Rossi P.
    Neuwirth, Clare
    Walji, Shahenaz
    Aitman, Timothy J.
    Scott, James
    Myant, Nicolas B.
    Soutar, Anne K.
    ATHEROSCLEROSIS, 2015, 243 (01) : 328 - 333
  • [30] GENETIC MUTATIONS AND LIPID-LOWERING RESPONSE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kim, H.
    Lee, S. H.
    ATHEROSCLEROSIS, 2020, 315 : E97 - E98